KOREA PHARMA Co., Ltd. (KOSDAQ: 032300)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,300
-420 (-2.67%)
Dec 20, 2024, 1:51 PM KST
-39.04%
Market Cap 166.76B
Revenue (ttm) 79.80B
Net Income (ttm) 3.00B
Shares Out 10.91M
EPS (ttm) 275.40
PE Ratio 55.52
Forward PE n/a
Dividend n/a
Ex-Dividend Date Dec 27, 2024
Volume 25,311
Open 15,990
Previous Close 15,720
Day's Range 15,250 - 15,990
52-Week Range 13,720 - 25,400
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About KOREA PHARMA

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 134
Stock Exchange KOSDAQ
Ticker Symbol 032300
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.